Rick Doblin is a leading advocate for psychedelic medicine, founding the Multidisciplinary Association for Psychedelic Studies (MAPS). He champions clinical research into MDMA-assisted therapy for PTSD, anxiety, and trauma. His work benefits patients, therapists, and researchers seeking legal, evidence-based psychedelic treatments, helping shift public policy toward medical acceptance and broader mental health access.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends